Treatment of HCV: Addressing Uncertainties With Confidence - Gilead Product Theater
Zoom Webinar • Thursday, January 14, 6:00-7:00 PM
Today’s patients with hepatitis C virus (HCV) are oftentimes younger, found among the population of people who inject drugs (PWID), and often possess many challenges. The “Addressing Uncertainties With Confidence” promotional presentation is designed to bring these challenges to light and to provide data and information around Gilead's treatment for HCV, including this subpopulation of patients. This short, didactic presentation includes an overview of the current HCV patient landscape, including common characteristics and uncertainties, as well as a review of prospective clinical data sets in the PWID with HCV population.
- To bring to the forefront the patient challenges that are commonly seen in clinical practice in today’s patients with HCV
- To provide a forum for discussion around treatment for today’s patients with HCV who also inject drugs
- To inform clinicians of the highlights of relevant data, including prospective data sets in the PWID with HCV population
Speaker: Anthony Martinez, MD | HIV Specialist/Hepatologist
As medical director of hepatology at ECMC hospital in New York, Dr. Anthony Martinez cares for outpatients with liver disease, including viral hepatitis, alcoholism, and fatty liver disease. In collaboration with the division of infectious diseases, he also evaluates and treats patients with hepatitis C virus (HCV) and HIV co-infection.
This webinar is a promotional program hosted by MDDCSAM Gold Partner Gilead Sciences, Inc. Its contents have been reviewed by the MDDCSAM Program & Education Committee for compliance with ethical standards for advertising and sponsorship. To learn more, visit: http://www.mddcsam.org/about-us/mddcsam-corporate-partnership-program